SEC Form 4 · accession 0001974200-26-000012
Mirum Pharmaceuticals, Inc. · MIRM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jolanda Howe
Officer — SVP, GLOBAL CONTROLLER
Period of report
Aug 18, 2026
Accepted (ET)
Aug 19, 2026 · 6:19 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001759425
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 18, 2026 | M | 40,000 | $6.27 | A | 41,274 | D | |
| Common Stock | Aug 18, 2026 | S | 40,000 | $100.00 | D | 1,274 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $6.27 | Aug 18, 2026 | M | 40,000 | D | — | May 13, 2029 | Common Stock | 40,000 | 0 | D |
Explanation of responses
- F1The stock option is fully vested.